Key statistics
On Friday, argenx SE (1AEA:DEU) closed at 478.00, -4.40% below its 52-week high of 500.00, set on Oct 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 486.00 |
---|---|
High | 496.00 |
Low | 478.00 |
Bid | 474.00 |
Offer | 490.00 |
Previous close | 500.00 |
Average volume | 1.00 |
---|---|
Shares outstanding | 59.80m |
Free float | 59.72m |
P/E (TTM) | -- |
Market cap | 31.69bn USD |
EPS (TTM) | -3.48 USD |
Data delayed at least 15 minutes, as of Oct 04 2024.
More ▼
- argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy
- argenx to Present at Upcoming Investor Conferences
- argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update
- argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024
- argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
- argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting
- argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
- argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024
- argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference
- argenx Reports First Quarter 2024 Financial Results and Provides Business Update
More ▼